Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CD169+ Monocyte and Regulatory T Cell Subsets Are Associated with Disease Activity in Rheumatoid Arthritis.

Journal of personalized medicine·2022

Same author

A Novel Processing-Free Method for RNAseq Analysis of Spontaneous Sputum in Chronic Obstructive Pulmonary Disease.

Frontiers in pharmacology·2021

Same author

Anti-tumour necrosis factor-alpha response associated with combined CD226 and HLA-DRB1[*]0404 haplotype in rheumatoid arthritis.

Clinical and experimental rheumatology·2021

Same author

Siglec-1 and -2 as potential biomarkers in autoimmune disease.

Proteomics. Clinical applications·2016

Same author

Current and future trends in biomarker discovery and development of companion diagnostics for arthritis.

Expert review of molecular diagnostics·2014

Same author

Implant positioning system using mutual inductance.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2013

Search research articles

Related Experiment Video

Updated: May 6, 2026

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

Camera phone-based quantitative analysis of C-reactive protein ELISA.

Cathy M McGeough, Stephen O'Driscoll

IEEE Transactions on Biomedical Circuits and Systems

|November 16, 2013

Summary

A camera phone can quantify high-sensitivity C-reactive protein (hs-CRP) using enzyme-linked immunosorbent assay (ELISA). This low-cost method offers accurate results comparable to lab instruments, enabling home-based monitoring of inflammatory diseases.

More Related Videos

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays

Published on: June 28, 2024

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Related Experiment Videos

Last Updated: May 6, 2026

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays

Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays

Published on: June 28, 2024

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Area of Science:

Biomedical Engineering
Clinical Chemistry
Point-of-Care Diagnostics

Background:

High-sensitivity C-reactive protein (hs-CRP) is a key biomarker for inflammatory diseases.
Quantitative analysis of hs-CRP typically requires expensive laboratory equipment.
Accessible and affordable diagnostic tools are needed for widespread health monitoring.

Purpose of the Study:

To evaluate the feasibility of using a camera phone as a low-cost optical detector for hs-CRP quantitative analysis.
To assess the accuracy and reliability of camera phone-based hs-CRP detection compared to conventional methods.
To explore the potential for home-based monitoring of inflammatory biomarkers.

Main Methods:

An enzyme-linked immunosorbent assay (ELISA) for hs-CRP was performed in a 96-well plate.
Images of the colorimetric ELISA results were captured using a camera phone.
Colorimetric analysis of the captured images was employed for quantitative determination.

Main Results:

A standard curve was generated from the camera phone images, showing excellent agreement with a 4-parameter logistic model (R²=0.998).
The limit of detection (LOD) for hs-CRP was determined to be 0.026 ± 0.002 μg/ml.
Results obtained using the camera phone method closely correlated with those from a laboratory-based instrument.

Conclusions:

Camera phone-based quantitative analysis of hs-CRP ELISA is a viable low-cost diagnostic approach.
This technology has the potential to enable convenient and affordable home-based monitoring of inflammatory diseases.
The widespread availability of camera phones presents an opportunity for accessible point-of-care diagnostics.